Changes to US and China Tariffs Have No Impact on TruScreen

GENERAL
Mon, Apr 07 2025 08:30 am

NZX/ASX Announcement

7/04/2025

Changes to US and China Tariff Regimes have no impact on TruScreen

• TruScreen’s unique AI enabled cervical cancer screening device is not impacted by changes to the US and China proposed tariff regimes
• Focus on emerging markets ensures TruScreen sales are unaffected by increased tariffs on Australian products entering the USA
• TruScreen markets both an Australian and a Made in China device providing a dual product strategy in the key China market, with preferential market access for China manufactured products
• China proposed retaliatory 34% tariff on US made products entering China strengthen TruScreen’s domestic manufactured advantage

TruScreen Group Limited (“TruScreen” or “the Company”) advises that its unique AI enabled cervical cancer screening device is not impacted by changes to the US and China proposed tariff regimes.

TruScreen has pursued an emerging markets strategy. The United States is currently not a distribution territory or strategic focus for TruScreen.

The TruScreen device is a particularly appropriate primary cervical cancer screening tool in regions with high mortality to cervical cancer. TruScreen’s growth strategy focuses on emerging markets, especially China, and Low and Middle Income Countries (LMICs) such as India, Indonesia, Mexico, Vietnam, Uzbekistan and Zimbabwe.

TruScreen manufactures both an Australian and a Chinese made device. This strategy de-risks government policy changes in the key China market, where there is a preferential purchasing policy for China manufactured products.

The announcement that China proposes to impose a retaliatory 34% tariff on US made products into China will strengthen TruScreen’s Made in China competitive advantage over imported US manufactured cytology (pap smear) and HPV DNA products.

This announcement has been approved by the Board.
Ends
For more information, visit www.truscreen.com or contact:
Martin Dillon
Chief Executive Officer
[email protected]

Guy Robertson
Chief Financial Officer
[email protected]


Announcement PDF


Markets News

NZ sharemarket down as retail spending stalls in new data
Markets Market Close

NZ sharemarket down as retail spending stalls in new data

April figures from Stats NZ show spending in the retail industry that month was flat.

Tom Raynel 14 May 2025
Finance

How Sharesies is providing ‘patient’ capital for listeds

The online platform is being tapped for bookbuilds and dividend reinvestment plans.

How Sharesies is providing ‘patient’ capital for listeds
Markets Market Close

NZX rallies 0.87% as tariff uncertainty eases

Skellerup bounced 4.11% as investors digested easing tariffs. 

Gregor Thompson 13 May 2025
NZX rallies 0.87% as tariff uncertainty eases